tirzepatide weight loss in one month ✨ patient — 6 months later🔥 40 pounds down and feeling stronger than ever 🙌 Thanks to healthy habits, consistency, and exercise, this patient didn't just lose — they were GLP-1 Weight Loss Medication Program

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

The diagnosis is based on the finding of cysteinylglycinuria and decreased activity of dipeptidase, and is established by: Increased urinary excretion of cysteinyl glycine Normal concentration of cysteinyl glycine in plasma Low activity of dipeptidase in cultured skin fibroblasts and/or red blood cells

Monitoring frequency should be individualised and agreed with your diabetes team, but typically includes testing before meals, before bed, and whenever symptoms occur

Additionally, it enhances glucose-dependent insulin secretion whilst suppressing inappropriate glucagon release, contributing to improved glycaemic controlparticularly beneficial for patients with type 2 diabetes or prediabetes